Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Incidence and prevalence of immune-mediated necrotizing myopathy in adults in Olmsted County, Minnesota.

Literature DB >> 35064938

Incidence and prevalence of immune-mediated necrotizing myopathy in adults in Olmsted County, Minnesota.

Shahar Shelly^1,2, Michelle M Mielke^1,3, Pritikanta Paul^1,4, Margherita Milone¹, Jennifer A Tracy¹, John R Mills⁵, Christopher J Klein¹, Floranne C Ernste⁶, Jay Mandrekar³, Teerin Liewluck¹.

Abstract

Entities: Chemical

Keywords: epidemiology; immune-mediated necrotizing myopathy; incidence; necrotizing autoimmune myopathy; prevalence; statin

Mesh：

Year: 2022 PMID： 35064938 PMCID： PMC9035036 DOI： 10.1002/mus.27504

Source DB: PubMed Journal: Muscle Nerve ISSN： 0148-639X Impact factor: 3.852

× No keyword cloud information.

19 in total

Review 1. Acquired necrotizing myopathies.

Authors: Yves Allenbach; Olivier Benveniste
Journal: Curr Opin Neurol Date: 2013-10 Impact factor: 5.710

Review 2. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis.

Authors: Jamie L Banks; Charles A Marotta
Journal: Stroke Date: 2007-02-01 Impact factor: 7.914

Review 3. Incidence and prevalence of inflammatory myopathies: a systematic review.

Authors: Alain Meyer; Nicolas Meyer; Mickael Schaeffer; Jacques-Eric Gottenberg; Bernard Geny; Jean Sibilia
Journal: Rheumatology (Oxford) Date: 2014-07-26 Impact factor: 7.580

4. 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016.

Authors: Yves Allenbach; Andrew L Mammen; Olivier Benveniste; Werner Stenzel
Journal: Neuromuscul Disord Date: 2017-10-23 Impact factor: 4.296

5. National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey.

Authors: Joseph A Salami; Haider Warraich; Javier Valero-Elizondo; Erica S Spatz; Nihar R Desai; Jamal S Rana; Salim S Virani; Ron Blankstein; Amit Khera; Michael J Blaha; Roger S Blumenthal; Donald Lloyd-Jones; Khurram Nasir
Journal: JAMA Cardiol Date: 2017-01-01 Impact factor: 14.676

6. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.

Authors: Jessie L Werner; Lisa Christopher-Stine; Sharon R Ghazarian; Katherine S Pak; Jordan E Kus; Natalie R Daya; Thomas E Lloyd; Andrew L Mammen
Journal: Arthritis Rheum Date: 2012-12

Incidence and prevalence of immune-mediated necrotizing myopathy in adults in Olmsted County, Minnesota.

Review 1. Acquired necrotizing myopathies.

Review 2. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis.

Review 3. Incidence and prevalence of inflammatory myopathies: a systematic review.

4. 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016.

5. National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey.

6. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.

7. HMGCR-associated myositis: a New Zealand case series and estimate of incidence.

8. Immune-mediated necrotizing myopathy: Unusual presentations of a treatable disease.

9. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.

10. Cardiac and Respiratory Complications of Necrotizing Autoimmune Myopathy.

1. Refractory Statin-Induced Immune-Mediated Necrotizing Myositis: Challenges and Perils in Its Management.